$6.61
+0 (+0%)
At Close: Apr 14, 2026
Athira Pharma recovers from Alzheimer's failure with breast cancer pivot and $90M investment
01:09pm, Thursday, 18'th Dec 2025
In a remarkable pivot, Athira Pharma has a deal to test a promising breast cancer drug and landed $90 million in upfront funding from investors.
Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations
Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand
12:15pm, Monday, 15'th Dec 2025
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WHITE ROCK, BRITISH CO
Generation Uranium Applauds ATHA Energy's Uranium Discoverys In The Angikuni Basin, South Of Generations YATH Project
08:30am, Thursday, 11'th Dec 2025
Vancouver, British Columbia – December 11, 2025 – TheNewswire - Generation Uranium Inc. (TSXV:GEN, OTCQB: GENRF) (the “Company” or “Generation”) is pleased to see Atha Energy's success in
Athena Gold Closes First Tranche of Non-Brokered Private Placement and Announces Further Upsize
07:00am, Tuesday, 09'th Dec 2025
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WHITE ROCK, BC / ACCES
Athena Gold Provides Exploration Update From Excelsior Gold-Silver Project, Nevada
07:00am, Wednesday, 26'th Nov 2025
Maiden diamond drilling returns 4.33 g/t Au over 14.4m; geophysics defines large intrusive WHITE ROCK, BC / ACCESS Newswire / November 26, 2025 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athe
HIGHLIGHTS Assays confirm the Company's maiden drillhole, RIBN-DD-001, at the RIB North Discovery as the best exploration hole drilled to date at the Angilak Uranium Project; RIBN-DD-001 assays return
ATHA Announces Filing of a Final Short Form Prospectus
02:45pm, Friday, 31'st Oct 2025
Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / October 31, 2025 / ATHA Energy Corp. (TSXV:SASK)(FRA:X5U)(OTCQB:S
ATHA Announces Filing of Annual Information Form and Preliminary Short Form Prospectus
10:25pm, Tuesday, 21'st Oct 2025
Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / October 21, 2025 / ATHA Energy Corp. (TSX.V:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA"
ATHA Clarifies Technical Disclosure and Files an Amended Technical Report for Angilak
10:20pm, Tuesday, 21'st Oct 2025
VANCOUVER, BC / ACCESS Newswire / October 21, 2025 / ATHA Energy Corp. (TSXV:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA" or the "Company") announces that, as a result of a review by the British Columbia Secur
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / September 23, 2025 / HIGHLIGHTS Major new discovery within the Mineralized RIB Corridor ("MRC"), the RIB North Discovery, located ~1.4 km along strike f
HIGHLIGHTS ATHA closes previously announced CAD $11.5 Million Over-Subscribed Bought Deal (See detail below, "Underwritten Private Placement"); First two drill holes completed at the RIB West Discover
Athira Pharma Announces Reverse Stock Split
09:00am, Thursday, 11'th Sep 2025
BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules
Athena Defines Geophysical Targets and Mobilizes Field Crew at Laird Lake
07:00am, Thursday, 11'th Sep 2025
ADDITIONAL UNTESTED GOLD TARGETS IN RED LAKE, ONTARIO WHITE ROCK, BC / ACCESS Newswire / September 11, 2025 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena" or the "Company") is pleased to
ATHA Files Updated Technical Reports
07:55pm, Wednesday, 10'th Sep 2025
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / September 10, 2025 / ATHA Energy Corp. (TSX.V:SASK)(FRA:X5U)(OTCQB:SASKF) ("ATHA" or the "Company"), as a result of a review by the British Columbia Sec
Sign In
Buy ATHA